US | pharmaphorum

US

News

Sandoz makes its first post-spinout acquisition

Newly independent drugmaker Sandoz has made its first acquisition since spinning out of Novartis last October, buying a brand from Coherus that will boost its position in

News

Biden may order compulsory licensing in drug pricing move

The White House said today that it may take enforced ownership of patents on medicines developed with public funding if their manufacturers set their prices too high.

News

Women in Alabama could face prosecution over use of abortion...

The Attorney General of Alabama has threatened to use an obscure law passed in 2006 to prosecute women who terminate a pregnancy using pharmacological means, shortly after the FDA made acce

News

close up of a prescription bottle with white tables falling out on top of a group of hundred dollar bills

Congress delivers festive PIE to patients, speeding access t...

After years of preparation, the US Congress passed the Pre-approval Information Exchange (PIE) Act just ahead of the Christmas break, legislation that will allow medical payers and the FDA

News

Whistleblower gets $250m as Biogen settles US kickbacks case

Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs.

News

Xenpozyme is first FDA-approved drug for rare disease ASMD

Sanofi now has approval on both sides of the Atlantic for Xenpozyme – its enzyme replacement therapy for rare disease acid sphingomyelinase deficiency (ASMD) – after getting a green light f

Sandoz makes its first post-spinout acquisition

Biden may order compulsory licensing in drug pricing move

Women in Alabama could face prosecution over use of abortion...

Congress delivers festive PIE to patients, speeding access t...

Whistleblower gets $250m as Biogen settles US kickbacks case

Xenpozyme is first FDA-approved drug for rare disease ASMD

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

US

Editor's Picks